More information: A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in ...

Medically reviewed by Allison Herries, RDN L-tyrosine is an amino acid that's often used in supplements to improve cognitive function affected by stress. Supplements containing L-tyrosine supplements ...

Tyrosine, a non-essential amino acid, is vital for the production of neurotransmitters like dopamine, norepinephrine, and epinephrine. These neurotransmitters play an essential part in regulating ...

A panelist discusses how first-line (1L) therapies, including EGFR tyrosine kinase inhibitors (TKIs) such as osimertinib, are the standard of care for treating locally advanced or metastatic ...

The U.S. Food and Drug Administration (FDA) has granted full approval to Vitrakvi (larotrectinib) for the treatment of adult ...

Tolebrutinib is an oral, brain-penetrant, and bioactive Bruton’s tyrosine kinase inhibitor that modulates peripheral ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of ...

The US Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients with previously treated advanced neuroendocrine tumors.

Panelists discuss how chronic myeloid leukemia (CML) treatment has evolved over the past 5 years, highlighting advancements in tyrosine kinase inhibitor (TKI) therapy, improved adverse effect ...